Keeping the promise: a critique of the current state of microdosing research.

The practice of taking small, sub-hallucinogenic doses of psychedelics, known as microdosing, has exploded in popularity over the last decade. Users claim benefits ranging from improved mood and enhanced creativity to an increased sense of meaning and connectedness in life. While research on microdosing is still lagging behind the shift in public opinion, several papers have been published in the last five years which attempted to assess the effects of microdosing. This review paper aimed to critically analyze the research practices used in the recent wave of microdosing research: We reviewed 15 papers published before the closing date of this review in March 2022. Our review concludes that it is premature to draw any conclusions about the efficacy or safety of microdosing since the research quality cannot be considered confirmatory. We propose some potential causes for the current state of the literature and some suggestions for how these causes may be ameliorated.

Informations de copyright

Copyright © 2024 Petranker, Anderson, Fewster, Aberman, Hazan, Gaffrey and Seli.

Déclaration de conflit d'intérêts

MH is the CEO of Energia Holdings Incorporated, a Managing Partner of Tabula Rasa Ventures, and the Executive Director of the Energia Foundation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.